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and ^Department o f  Pathology, University Hospital N ijmegen, Nijmegen, The Netherlands
Tenascin-C is a large hexam eric extracellular m atrix  
glycoprotein that is expressed in a tem porally  and 
spatially restricted pattern associated w ith  strom al- 
epithelial interactions. In adult hum an skin, the ex­
pression level o f  tenascin-C  Is low , but tenascin-C  is 
abundantly present in  the derm al com partm ent dur­
in g  em bryogenesis and w ound healing  and in  skin 
tumors. H erein w e have in vestigated  the cellular  
source o f  tenascin-C  production  in  hum an skin, both  
in vivo and in vitro, by using im m unohis to chem istry, 
m RNA in situ hybridization, w estern  b lo ttin g , and an 
enzym e-linked im m unosorbent assay. In addition we  
studied the cell-m atrix  in teraction  b etw een  epider­
m al keratinocytes and purified tenascin -C . By using  
in vitro culture m odels, we found that keratinocytes  
not only synthesize and secrete tenascin-C  but can 
also deposit tenascin-C  in de-ep iderm ized  derm is in a
pattern that is very sim ilar to that in vivo. In vivo„ 
during w ound healing o f  normal human skin, we 
found tenascin-C  extracellularly in the wound bed 
and also in a granular pattern within the neo-epider­
mis. By m RNA in situ hybridization, we could identify 
the basal m igrated keratinocytes as the main source 
o f  tenascin-C  in  the early phase o f  wound healing. In 
the granulation phase, tenascin-C expression by the 
keratinocytes is dow nregulated. Cultured keratino­
cytes were found to adhere poorly to tenascin-C, and 
those that did adhere retained a rounded morphol­
ogy- W e conclude that human keratinocytes are a 
major source o f  tenascin-C  during the early phase o f  
w ound healing, and we hypothesize that tenascin-C  
is unlikely to be an adhesive substrate for migrating 
keratinocytes. Key tvords: in situ hybridization/epitheli­
um! cell adhesion. J  Invest Dermatol 108:776-783, 1997
T enascin-C is a large hexameric extracellular matrix glycoprotein consisting o f  subunits o f  220 -320  kDa that are linked by disulfide bonds (for review  see Schenk and Chiquet Ehrismann, 1994; Chiquet 
Ehrismann et al, 1994; and Lightner, 1994). The 
tenascin-C subunits have a m odular structure, in liumans forming a 
cysteine-rich domain at the N  terminus, followed by 14-5 domains 
with homology to epidermal grow th factor, a num ber o f  fibronec- 
tin type III repeats (varying from 9 to 16 as a result o f  alternative 
splicing of tenascin-C R N A ), and a fibrinogen-like domain at the C 
terminus. Recently, two proteins w ith the same general structure 
have been described, nam ed tenascin-R  (or restrictin) and tenas- 
cin-X. In analogy, tenascin is called tenascin-C in m ore recent 
literature, where the C  stands for cytotactin, a synonym for 
tenascin.
Teuascin-C is abundant during embryogenesis, particularly at 
mcsenchymal-epithelial interaction sites (Crossin et al, 1986; 
Aufderheide et aly 1987; Aufderheide and Ekblom, 1988; Ekblom 
and Aufderheide, 1989; Vainio et. al, 1989; C huong et al, 1991), but 
expression is limited in adult tissues. In norm al skin tenascin-C  is
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detected in the dermis, where it is sparsely distributed at the 
dermal—epidermal junction and surrounds blood vessels and epi­
dermal adnexa (Lightner et al, 1989; Schalkwijk et al, 1991b; 
Shikata et al, 1994). In conditions of epidermal hyper-proliferation, 
such as psoriasis (Schalkwijk et al, 1991b), epidermal tumors 
(Stamp, 1989; Schalkwijk et al, 1991b; Verstraeten et al, 1992; 
Shikata et al, 1994), and injury (Schalkwijk et al, 1991a; Betz et al, 
1993; Juhasz et al, 1993; Latijnhouwers et al, 1996), tenascin-C 
expression in the papillary dermis is strongly upregulated. The role 
o f  tenascin-C in vivo is still a matter of debate. In vitro studies have 
suggested various functions for tenascin-C, including modulation 
o f  cell proliferation and cell adhesion (Chiquet Ehrismann et al, 
1988; Friedlander et al, 1988; Lotz et al, 1989; Spring et al, 1989; 
Lightner and Erickson, 1990; M urphy Ullrich et al, 1991; Prieto et 
al, 1992, 1993) and suppression o f  the immune response (Ruegg et 
al, 1989; Hemesath et al, 1994). Knocking out the tenascin-C gene in 
mice, however, does no t induce marked phenotypic changes, 
W h e th e r  the tenascin-C-like molecules tenascin-R and tenascin-X 
in these knock-out mice take over the functions that are normally 
exhibited by tenascin-C is not yet clear.
For many tissues, reports pointed to mesenchymal cells as the 
cellular source of tenascin-C, whereas epithelial cells induce or 
m odulate tenascin-C production. W hen mesenchyme is co-cul­
ture d w ith  epithelial cells, for example, mesenchymal tenascin-C 
expression is induced (Aufderheide and Ekblom, 1988; Inaguma et 
al, 1988). In vivo, increase in mesenchymal tenascin-C also corre­
lates w ith epithelial changes, notably epidermal hyper-proliferation 
in skin (Stamp, 1989; Schalkwijk et ai, 1991a, 1991b; Verstraeten et
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al, 1992; Betz et al, 1993; Juhasz et al, 1993; Shikata et al, 1994; 
Latijnhouwers et al, 1996). Consequently, epidermal keratinocytes 
were considered to merely stimulate tenascin-C production of 
dermal fibroblasts in skin. More recently, how ever, epithelial cells 
were reported to produce tenascin-C as well. Cells may secrete 
tenascin-C only when cultured in vitro (Kawakatsu et al, 1992) and 
not after injection in nude mice (Sakai et al, 1993), although the 
opposite is possible as well (Hiraiwa et al, 1993). Immunohisto- 
chemically, tenascin-C was detected in developing corneal epithe­
lium (Kaplony et al, 1991), epithelial lung tum or cells (Soini et al, 
1993), human amnion cells (Linnala et al, 1993), and hum an breast 
tissue (Lightner et al, 1994). It should be noted, how ever, that the 
extracellular localization o f  tenascin-C hampers the immunohisto- 
chemical identification o f  cells expressing tenascin-C. In situ hy­
bridization is the preferred approach to identify the cellular source 
o f  tenascin-C. By in situ hybridization, tenascin-C  m R N A  was 
detected  in the epithelium o f developing bronchi (Prieto et al, 1990; 
K och et al, 1991) in normal and malignant breast epithelium 
{Lightner et al, 1994) and cornea (Tucker, 1991). In the epithelium 
o f  developing chicken feather buds, how ever, no tenascin-C 
m R N A  was found (Prieto et alf 1990). These findings o f  epithelial 
tenascin-C  expression led us to further examine tenascin-C  expres­
sion in skin. Our data demonstrate that epidermal keratinocytes 
secrete tenascin-C and deposit tenascin-C in the extracellular 
m atrix  in vitro and in vivo during wound healing. In addition we 
investigated the effect o f  tenascin-C in cell adhesion assays. The 
results indicate that tenascin-C is a poor adhesive substrate for 
cu ltu red  keratinocytes.
MATERIALS AND M ETHODS
C e l ls  a n d  C u l tu re  C o n d i t io n s  Tcnascin-C production was examined in 
h um an  glioblastoma and osteosarcoma cell lines and in primary cultures o f  
ep iderm al keratinocytes and dermal fibroblasts. T h e  hum an  glioblastoma 
cell lines U87-MG, U138-MG, and U373-MG w ere  provided by R . 
V erstraeten  (Free University o f  Amsterdam, The Netherlands), and Saos-2 
sarcom a cells were a gift from E. Mackie (Royal Veterinary College, 
L ondon , United Kingdom). The cel] lines are available from the American 
Type C ultu re  Collection (Rockville, MD) asH TB14, H TB 16, HTB17, and 
H T B 8 5 , respectively. All cultured cells were tested negative for myco­
plasma.
Cell lines and dermal fibroblasts were grown in D u lb ecco ‘s modified 
Eagle’s m edium  (DMEM)/F-12, 3:1 (vol/vol), supplemented with penicil­
lin (100  units per ml) plus streptomycin (100 jitg per  ml) and 10% fetal 
bov ine  serum. Human keratinocytes from skin biopsies o f  healthy donors 
w ere  initially cultured by the method o f  Rheinwald and Green (1975). 
Keratinocytes from these cultures were again seeded on  a feeder layer o f  
irradiated  3T3 cells or, alternatively, in serum-free m edium . For the method 
o f  R heinw ald  and Green, DMEM/F-12, 3:1 (vol/vol), supplemented with 
0.4 |U.g hydrocortisone per ml, 1 jU,M isoproterenol, 10 ng  epidermal growth 
factor p e r  ml, 6% fetal bovine serum, 100 units penicillin p e r  ml, and 100 jug 
streptom ycin per ml was used. Serum-free culture m edium  was keratinocyte 
g ro w th  medium (KGM). KGM was composed o f  keratinocyte basal me­
d ium  (Clonetics, San Diego, CA; 0.15 mM calcium) supplem ented with 0.1 
m M  ethanol amine, 0.1 M phosphoethanolamine, 10 ng  epidermal growth 
factor per  ml, 5 (ig insulin per ml, 0.4% (vol/vol) bovine pituitary extract 
(C lonetics, San Diego, CA), 0.5 ¡xg hydrocortisone per  ml, 100 units 
penicillin per ml, and 100 fig streptomycin per ml.
Before reaching confluency, the serum concentration o f  serum-contain- 
ing  m ed ium  was lowered to 1%. After 3 d, m edium  was collected and 
t e n a s c i n - C  concentrations were determined by an enzym e-linked immu­
n o so rb e n t  assay (ELISA).
In  Vitro  R e c o n s t r u c t io n  o f  E p id e rm is  o n  D e - E p i d e r m i z e d  D e rm is  
(D E D )  Keratinocytes cultured by the method o f  R heinw ald  and Green 
w ere  seeded on DED and cultured in DM EM /F-12, 3:1 (vol/vol), supple­
m e n te d  with 5% HyClone newborn bovine serum (Greiner, Alphen a /d  
R ijn , T h e  Netherlands), 0.4 /¿-g hydrocortisone per ml, 1 /xM isoproterenol, 
and  5 ju,g insulin per ml. Cultures were maintained subm erged in the 
m e d iu m  for 3 d and then were air-exposed for another 3—14 d. T h e  medium 
used for air-exposed culture was supplemented w ith  10 ng  epidermal 
g ro w th  factor per ml. Generation of DED and culture m ethods  have been 
described previously (Prunieras et al, 1983; Ponec, 1991).
B io p s i e s  Experimental wounds were made by taking partial thickness 
p un ch  biopsies with a diameter of 3 mm from the upper  arm o f  healthy
volunteers. Full-thickness punch biopsies with a diameter o f  4 mm were 
taken from the different wounds after 2, 4, 7, 14, 60, and 365 d, These 
secondary biopsies, w hich included the healing wounds and some o f  the 
adjacent normal skin, were em bedded  in Tissue T e k  O T C  compound and 
stored at ~ 80°C  until use or w ere formalin-fixed and embedded in paraffin. 
Permission for experiments on hum ans was obtained from the Medical 
Ethical Comm ittee o f  the University Hospital in Nijmegen.
A n t i s e r u m  Antibodies directed against hum an  tenascin-C were the 
mouse monoclonal antibodies T 2 H 5  (for reference, see Schalkwijk et al, 
1991a) and T N 2  (Dako, Glostrup, D enm ark) and two rabbit polyclonal 
antiserums A107 and TN 953 . A107 was obta ined  from Chcmicon Interna­
tional (Temecula, CA). W e  raised T N 953  in N e w  Zealand White rabbits by 
immunization with highly purified hum an  tenascin-C from U138-MG cells. 
Traces o f  anti-fibronectin reactivity in T N 953  w ere removed by solid-phase 
absorption with hum an fibronectin. Antibodies against human fibronectin 
were a mouse monoclonal antibody (Sigma-Aldrich, Bornem, Belgium) and 
a rabbit polyclonal antiserum (Life Technologies, Breda, The Netherlands).
I m m u n o h i s t o  c h e m i s t r y  T 2 H 5 , T N 2 , and T N 953  were used for stain­
ing  o f  tenascin-C in cryostaf sections. In addition, T N 2 , TN953, and A107 
were applied to detect tenascin-C in formalin-fixed sections. Staining with 
T2H 5 was perform ed by an indirect im immoperoxidase staining protocol 
described previously that uses 3-amitio-9-ethylcarbazole as a chromogenic 
substrate (Schalkwijk ct al, 1991a). For T N 2 , TN 953, and A107, the 
Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA) was used 
according to the manufacturer’s instructions, w ith  diaminobenzidine as a 
chromogenic substrate, After immunostiiining, sections were counterstained 
with hematoxylin.
E L ISA  T o  quantify tenascin-C concentrations in culture medium, a 
sandwich-type ELISA was developed that is similar to the one described by 
Schenk and colleagues (1995). Polystyrene microtiter plates were coated 
with T2H5. After blocking free protein binding sites with bovine serum 
albumin (BSA), dilution series o f  samples, standard, and blanks were 
incubated in the wells, and A107 was subsequently used to detect bound 
tenascin-C. A107 binding was assessed w ith  peroxidase-conjugated swine 
anti-rabbit immunoglobulins and o-phenylene diamine dihydro chloride as 
the chromogenic substrate. T he  color reaction was stopped by adding 4 M  
H 2SO.( and evaluated by reading the absorption o f  the color product at 490 
nm, with 655 nm  as a reference wavelength. T he  same method was applied 
for the fibronectin-specific ELISA. For these a mouse monoclonal antibody 
and a rabbit polyclonal antiserum against hum an fibronectin were used. 
Chicken egg ovalbumin was used instead o f  BSA in the fibronectin ELISA.
T he  standards used in ELISAs w ere  hum an  tenascin-C purified from the 
melanoma cell line SK-MEL-28 by L. Zardi (Instituto Nazionale per la 
Ricerca sul Cancro, Genoa, Italy) and fibronectin from human plasma (0.1% 
solution, Sigma-Aldrich, Bom em , Belgium). T h e  detection limits were 
approximately 20  ng tenascin-C p e r  ml or 80 ng  fibronectin per ml, 
respectively.
C o n s t r u c t i o n  o f  P la s m id s  a n d  S y n th e s is  o f  R N A  P ro b e s  Total 
R N A  was isolated from cultured hum an dermal fibroblasts, and cDNA was 
synthesized by reverse transcription w ith  oligo(dT) primers. Part o f the 
cD N A  was amplified by using a polymerase chain reaction and subcloned in 
pGEM-3. T he  tenascin-C-coding insert corresponds to nucleotides 6016— 
6475 o f  the hum an  tenascin-C cD N A  sequence as submitted by Gherzi and 
colleagues to the EMBL Database Library (accession number X78565), 
spanning part o f  the most C-terminally located fibronectin type III repeat 
and part o f  the fibrinogen-like domain.
T h e  plasmid was linearized w ith  BautH I to  synthesize an anti-sense 
complementary R N A  probe by using T 7  polymerase and with EcoRI to 
synthesize control sense com plem entary  R N A  by using Sp6 polymerase in 
the reverse orientation. D ioxigenin (DIG)-labeled anti-sense and sense 
probes were synthesized by using a S p 6 /T 7  in vitro R N A  synthesis lot in the 
presence o f  D IG -U T P  (Boehringer M annheim , Mannheim, Germany). 
Synthesis was perform ed at 37°C w ith  T7 polymerase and at 40°C with Sp6 
polymerase. The anti-sense probe thus produced was 471 nucleotides long, 
and the sense probe was 498 nucleotides long.
In  S itu  H y b r i d i z a t i o n  In situ hybridization was performed on frozen 
sections as described (Pfundt et 1996) w ith  the modification that the 0 .1X 
sodium citrate/chloride buffer used to wash slides after hybridization 
contained 60% form amide instead o f  50%. Optim al probe concentrations 
were determined in a pilot experim ent: 200 ng per ml was choosen for 
further use. Hybridization was assessed with Fab fragments o f  sheep 
anti-DIG m onoclonal antibodies conjugated to alkaline phosphatase 
(Boehringer M annheim) and subsequent staining with nitro blue tetrazo- 
lium and 5-brom o-4-chloro-4-indolyl phosphate.
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T e n a s c in -C  P u r i f i c a t i o n  U 138-M G  was used for tenascin-C purifica­
tion. Before the cells reached confluency, the serum concentration o f  the 
medium was lowered to 1 % fetal bovine serum and cultures w ere main- 
tained for an additional 2 mo, during w hich  m edium  was collected every 3 
or 4 d for tenascin-C purification. Proteinase inhibitors (2 m M  ethylenedi- 
amine tetraacetic acid, 0.3 mM  phenylmethylsulfonyl fluoride, and 2 fig 
aprotinin per ml) and  0.05% N a N 3 w ere  added to the collected medium. 
The medmm was subjected to two rounds o f  anion-exchange chrom atog­
raphy. First, tenascin-C was eluted from hydroxyl apatite in a batchwise 
manner with increasing concentrations o f  N a 2H P 0 40*12H20 .  T h e  fractions 
that contained most o f  the tcnascin-C w ere  used for final purification on the 
Smart System using a M ono Q  HR. 5 /5  colum n (Pharmacia, Uppsala, 
Sweden) and a gradient o f  0.1-1 M  N aC l in 20 m M  Tris(hydroxymethyl) 
aminomethane (pH 7.9). In this way, tenascin-C could be quantitatively 
separated from fibronectin (see F ig  6). T he  concentration o f  purified 
tenascin-C was quantified by ELISA. Qualitative analysis included fibronec- 
tin specific ELISA and western blotting, In addition, the hemagglutinating 
activity o f  the tenascin-C preparations was verified (Erickson and Inglesias, 
1984; Chiquet Ehrismann et al, 1986). O n  western blots o f  reduced 
tenascin-C, specific antiserum stained tw o  tenascin-C bands w ith  molccular 
weights exceeding 200 kDa. The only contam inating proteins w ere traces o f  
fibronectin and BSA; laminin was not detected. According to ELISA results, 
the purified tenascin-C typically contained less than 3% fibronectin.
C ell  A d h e s io n  A ssays  Adhesive proteins used in the adhesion assays 
were fibronectin from human plasma (Q.1% solution, Sigma-Aldrich, 
Borncm, Belgium), laminin purified from hum an placenta (Life Technolo­
gies, Breda, The Netherlands), tenascin-C purified from the glioblastoma 
cell line U251-MG (Chemicon International, Temecula, CA)> and hum an 
tenascin-C that we purified ourselves from the glioblastoma cell line 
U138-MG. Polystyrene microtiter plates w ere coated by incubation over­
night at 4°C with 50 (jl\ o f  a solution containing the appropriate protein 
diluted in Dulbecco’s PBS (DPBS — PBS containing 0.9 m M  C aC l2 • 2H 20  
and 0.49 mM MgCI2 * 6H 20 ). U n b o u n d  protein was rem oved by washing 
with DPBS and free protein  binding sites w ere  blocked by incubation for 1 h 
at 37°C with DPBS containing 1 % BSA.
For adhesion assays only secondary cultures o f  keratinocytes w ere  used. 
Cells from subconfluent keratinocyte cultures w ere harvested by trypsiniza- 
tion and subsequently resuspended ill DPBS w ith  5% fetal calf serum to 
inactivate trypsin. In cases where keratinocytes had been  cultured according 
to the method o f  Rheinw ald  and Green, the feeder cells w ere rem oved  witli 
ethylenediamine tetraacetic acid prior to trypsinization. After tw o  washes in 
succession with DPBS and DM EM  supplem ented with 0.25% BSA and 20 
m M  HEPES (pH 7.4), cells were resuspended in D M EM , 0.25% BSA, and 
20 m M  HEPES (pH 7.4) and seeded into the wells (5000—10,000 cells per 
well). Cells were allowed to attach for 2 h at 37°C  in a 8% C 0 2 humid 
atmosphere. N on-adherent cells were rem oved  by washing w ith  200 ju.1 
DPBS per well until the cells in the BSA-coated control wells were 
sufficiently removed as m onitored by visual inspection. Typically this took
3 washes. The attached cells were fixed w ith  3.8% phosphate buffered 
formalin and stained with 0.5% toluidine blue. Attached cells w ere  counted 
directly or quantified by m easurem ent o f  the absorbance at 655 lini after 
solubilizing the cell bound toluidine blue in 100 jutl cetramide buffer (0.4% 
cetyltrimethylammoniumbromide, 0.1 M  T ris(hydroxym ethyl)am inom eth­
ane (pH 8.5), 1 M N aC l) .  The num ber o f  cells was read from a calibration 
curve that was obtained by plotting the n um b er  o f  cells as determ ined by 
directly counting against the absorbance measured.
Phorbol esters can stimulate integrm ligand-binding capacity ofin tegrins, 
presumably by inducing conformational changes (D iam ond and Springer, 
1994). In adhésion-stimulation assays, keratinocytes were, therefore, seeded 
in the presence of 25 nM  phorbol 12-myristate 13-acetate (PMA, Sigma- 
Aldrich, Bornem, Belgium). In inhibition assays, antiserum was used to 
block the coated adhesive protein before seeding the cells by incubating 
coated wells with a saturating concentration o f  the appropriate antiserum in 
DPBS with 1 % BSA for 1.5 h at 37°C.
AH assays were perform ed at least in duplicate, and in individual assays, 
triplicate or quadruplicate wells w ere  used for each assay condition. 
Adhesion results w ere donor-independent as comparable results were 
obtained with keratinocytes of different individuals.
RESULTS
T en ascin -C  P r o d u c tio n  b y  C u ltu red  C ells  T o  investigate the 
ability o f  several cell lines and primary cultures o f  hum an skin cells 
to produce tenascin-C, the tenascin-C  concentration in the condi­
tioned medium was assessed by a sandwich ELISA. Results are 
summarized in T ab le  I. In the unconditioned culture m edium , no 
tenascin-C was detected. Glioblastoma and sarcoma cell lines
T able I. T en a sc in -C  Is D etec ted  in the C onditioned  
M ed iu m  o f  T u m o r  C ell L ines and C ultured N orm al Skin
C ells  by ELISA
T N -C  Concentration '7 
Cell Type (/xg/ml)
U87-M G 2.07 ± 0.74
U138-M G 5.22 ±  0.07
U373-MG 2.28 ±  0.19
Saos-2 1.12 ± 0.24
Dermal fibroblast 1.04 ±  0.13
Epidermal keratinocyte* 0.49 ±  0.06
Epidermal keratinocyte* 0.21 ±  0.07
Data are duplicate tenascin measurements (ELISA). Comparable results were 
obtained for different cultures o f  the same cell types. TN -C, tenascin-C. 
h Cultured according to the m ethod  o f  Rheinwald and Green.
‘ Serum-free culture in KGM.
secreted large amounts o f  tenascin-C, as was reported previously 
(Erickson and Bourdon, 1989; Mackie and Tucker, 1992), and of 
these, U138-M G was chosen as producer cell line for tenascin-C 
that was used in adhesion assays. Medium o f  dermal fibroblast 
cultures contained tenascin-C as well. Remarkably, tenascin-C was 
also detected in the m edium  o f  epidermal keratinocytes, cultured 
on a feeder layer o f  irradiated mouse fibroblasts by the method of 
Rheinwald and Green or in the serum-free medium KGM. Western 
blot analysis o f  tenascin-C in the supernatants o f  cultured kerati­
nocytes under reducing conditions revealed the presence of two 
immunoreactive bands w ith  molecular weights greater than 200 
kDa (data not shown). It should be noted that because o f  differences 
in cell num ber and m edium  volume in the various cultures, the 
absolute amounts o f  tenascin-C produced cannot be compared 
directly.
T en a sc in -C  D e p o s it io n  b y  K eratinocytes C ultured  on DED
W e used an in vitro m odel for reconstructed epidermis to investigate 
w hether tenascin-C is also produced in a culture model that allows 
full stratification o f  the keratinocytes and to analyze whether 
tenascin-C is deposited in the extracellular matrix or is only 
secreted in the medium. In this model keratinocytes are seeded on 
DED. The DED is prepared for culture in such a way that no viable 
cells remain in the tissue. This was confirmed by hematoxylin 
staining o f  DED, which demonstrated that no nuclei were present 
in the DED. Immuno his to chemical staining of DED with tenas- 
cin-C  antiserum (T2H5, T N 2, A307, and TN953) was virtually 
negative. W h en  keratinocytes were seeded on a layer o f DED, 
however, marked tenascin-C staining was observed in the DED, 
indicating that the keratinocytes produce tenascin-C that is depos­
ited in the DED underneath. Tenascin-C was detected after 3 d of 
submerged culture, w hen the cultures resemble a squamous non­
keratinizing epithelium. Tenascin-C  remained present at the der­
m al-epiderm al junction during subsequent air exposure, which 
induces terminal differentiation o f  the keratinocytes as indicated by 
the formation of a stratum  corneum (Fig 1).
K eratin ocytes  E xpress T en ascin -C  during W o u n d  H ealing
In a previous study, w e described tenascin-C expression in healing 
wounds during a 14-d time course and its relationship with 
epidermal hyper-proliferation (Latijnhouwers et al, 1996). W e now 
have extended the time course to 1 y, and instead o f  one polyclonal 
tenascin-C antiserum (i.e., A107), we have now  used a panel of 
m onoclonal antibodies and polyclonal antiserum in combination 
w ith a more sensitive staining protocol, which indicates that the 
expression levels o f  tenascin-C in healing skin wounds are much 
higher than previously anticipated. In addition to the known 
increase o f  tenascin-C expression in the papillary dermis at the 
w ound margins, w e noticed a thin discontinuous line of staining 
beneath migrated keratinocytes. Both with the polyclonal anti­
serum and the m onoclonal antibodies, deposition of tenascin-C in 
the w ound bed was observed beneath the entire sheet o f migrating
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F igu re 6. T enascin-C  purification. Silver staining o f  
gel electrophoresed under reducing conditions
U138-M G cells
o f  the Mono
i 4-20%  gradient 
culture medium of 
ne 2, fraction eluted from h y d ro x y 1 a pat i t e; lane J, fraction
column containing fibronectin and BSA; latte 4 , final
C preparation separation on the M ono column: lane 5
commercially available tenascin-C; lane 6, molecular weight markers
w hen thev are cultured without feeder in serum-free medium,,
serum- or feeder-derived factors are not necessary to 
induce tenascin-C production. Immunohistochemical analysis of
reconstructed epidermis showed that keratinocytes in vitro are able 
to deposit tenascin-C in the extracellular matrix as well. Tenas­
c in -C  was detected in cultures that were maintained submerged in
air-exposed culture. W hether this is caused by continued tenas
c in -C  expression or
cannot
turnover o f previously made protein
I t i  ff*F—ÿiiw? :JfL-
estingly, the site of tenascin-C deposition, namely the dermal 
epidermal junction o f  the cultures, corresponds to the location, of
.JL .JL
tenascin-C in vivo. These in vitro models, the monolayer keratino-
cyte culture systems and the reconstructed epidermis, should be 
useful when further investigating the regulation and effects of 
epidermal tenascin-C expression.
The finding that keratinocytes express tenascin-C in vitro is 
clearly relevant for the in vivo situation, as we could detect 
tenascin-C in the epidermis of healing skin wounds at the protein 
and the m R N A  levels. Epidermal tenascin-C expression was pre 
viously demonstrated in feeder-cultured human keratinocytes1 and 
in amphibian epidermis (Onda et al, 1991). R ecently, Aukhil and 
colleagues (1996) reported on. tenascin-C expression by keratino 
cytes during healing of incisional wounds in rats where they 
observed expression patters similar to what we found in human 
tissue.. In a previous report we concluded that keratinocytes could
interact with tenascin-C in the later stages o f  wound 
healing but were unlikely to come into contact with tenascin-C in 
the early phase because of the undetectable levels o f tenascin-C  
under the migrating keratinocytes (Latijnhouwers et al, 1996), We, 
however, have now used a panel of polyclonal and monoclonal 
antibodies combined with a much more sensitive staining protocol
.««MW
7
that indicates that the of C are much
higher than previously anticipated. In this study we could detect 
tenascin-C in the dermis underneath the migrating keratinocytes. In 
addition, keratinocytes themselves are stained for tenascin-C pro­
tein. In situ hybridization results indicate that in the early phase of 
w ound healing, before wound closure, of the neo­
epidermis are the major source o f tenascin-C. By the time that the
wounds are closed, tenascin-C production in the neo-epidermis is
1 Lightner VA and Singer H: Cultured keratinocytes synthesize a#a»
chion/tenascin. J  Invest Derm atol 92:471, 1989 (abstr)
Tenascin Fibronectin
F ig u re  7. A dhesion  to  fib ronectin , a n d  tenascin-C  o f  k e ra tin o cy te s  
cultured  in  KGM or by the m e th o d  o f R heinw ald  and Green. Assays 
were performed with (M) or without (□) PMA. Adhesion without PM A
was performed in triplicate or quadruplicate in six experiments, and the
effect o f  PMA was tested six and three times for feeder-cultured and 
KGM-cultured cells, respectively. Representative data from one of these 
experiments are shown. Error bars, SEM (n =
accompanied by abundant dermal tenascin-C expression in the
granulation, tissue. Subsequently m R N A  synthesis decreases: at day
the dermis or the14 after wounding very few cells in
epidermis express tenascin-C m R N A . In contrast, tenascin-C pro­
tein is most abundant at day 14, indicating that maximum protein
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.Figure 8 . A d hesion  o f  feed er -cu ltu red  keratinocytes. A comparison
is made between adhesion to laminm (LN), fibronectin (FN), commercially 
available human tenascin-C (TN com), and tenascin-C that we purified 
from human glioblastoma cells (TN). Proteins were coated at a concentra­
tion of .20 fig  per ml, except for purified tenascin-C, which was used at 4,
20, and 100 ¡jlg per ml. Adhesion w ithout PMA was compared to
in the presence of PMA (H)* O ne representative experiment of six 
experiments is shown. Error bars, SEM. fn = 4 (LN and FN) or 3
(TN com and TN) ]
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F ig u re  9. K e ra t in o c y te  m o r p h o lo g y  in  a d h e s i o n  assays .  Values 
indicate the percentages o f  the attached feeder-cultured keratinocytes that 
have spread. Data were obtained from three or four separate experiments. 
Error bars, SEM [laminin (LN) and fibronectin (FN), n =  12 (w ithout PMA) 
and n = 5 (with PMA), respectively; tenascin-C (TN ), n  =  12 in both 
conditions].
levels are reached later than m axim um  m R N A  levels and that the 
turnover o f tenascin-C in the w ounds is rather slow.
Because tenascin-C is detected beneath  the m igrating keratino­
cytes that do no t encounter an intact basal m em brane structure 
(Latijnhouwers ct al, 1996), we w ondered  w hether it may function 
as a kind o f  provisionary matrix to w hich  these keratinocytes 
adhere. The results o f  the adhesion assays indicate that keratino­
cytes adhere poorly to tenascin-C. Therefore , tenascin-C  does no t 
seem to be an important adhesive substrate for keratinocytes. A 
prerequisite for tenascin-C having a direct effect on  keratinocytes is 
interaction between kei-atinocytes and tenascin-C, w hich  is most 
likely receptor-mediated. In the adhesion assays, very few kerati­
nocytes remained attached to tenascin-C, suggesting that interac­
tions between such putative receptors on kcratinocytes and tenas­
cin-C are not very strong. It should be noted , how ever, that strong 
intracellular effects may be evoked in spite o f  w eak receptor 
binding. This was recently reported for the interaction betw een 
fibronectin and a v integrins (Schwartz and Denninghoff, 1994). 
Although fibronectin binding to these receptors is m uch w eaker 
than binding to a 5j8t , the former interaction evokes the rise in 
intracellular Ca2H~ that was observed in cells that adhered to 
fibronectin.
Although tenascin-C does not m ediate strong keratinocyte ad­
hesion, it may well affect adhesion o f  keratinocytes to other 
proteins. It is known, for example, that tenascin-C  inhibits fi­
bronectin adhesion of various cells (Lotz et al, 1989; Lightner and 
Erickson, 1990; Murphy Ullrich et al, 1991; Prieto et al, 1993). 
Modulation o f  keratinocyte adhesion might be a m ajor function of 
tenascin-C in vivo. This may be especially im portant during wound 
healing, where keratinocytes have to migrate to close the w ound. 
Tenascin-C might facilitate keratinocyte m igration by w eakening 
the adhesion to fibronectin and possibly other extracellular matrix 
proteins that could otherwise interfere w ith  keratinocyte migration 
and subsequent wound closure. M odulation o f  keratinocyte adhe­
sion by tenascin-C is likely to be receptor-m ediated. In the 
literature, various tenascin-C receptors have been  described (Bour­
don and Ruoslahti, 1989; Salmivirta et al, 1991; Prieto et al, 1993; 
Sriramarao et al, 1993; Bamea et al, 1994; C hung  and Erickson, 
1994; Vaughan et. al, 1994; Yokosaki et al, 1994; V arnum  Finney et 
al, 1995), and o f  these, the a v/36 integrin is an interesting candidate. 
Keratinocytes normally do not express a vj36 bu t expression is 
induced in vitro after subculturing o f  keratinocytes and in vivo cev)36 
is expressed by wound keratinocytes (Breuss et al, 1995; Haapasalmi 
et al, 1996). The site o f  G!vj36 expression, namely, the basal 
keratinocytes o f  the neo-epidermis, and the level o f  expres­
sion coincide with the site and level o f tenascin-C expression. 
Receptors other than a vj36 could also bring about adhesion mod­
ulation by tenascin-C, such as the j3t integrins. Expression o f  /3t 
integrins generally is strongly upregulated in wounds (Grinnell,
1992; Hertle et al, 1992; Laijava et al, 1993; W a tt and Jones, 1993) 
and various /3l integrins are able to bind tenascin-C (Bourdon and 
Ruoslahti, 1989; Prieto et al, 1993; Sriramarao et al, 1993; Yokosaki 
et al, 1994; Varnum Finney et al, 1995). Among the non-integrin- 
type tenascin-C receptors described, syndecan and annexin II could 
be important (Salmivirta et al, 1991; Chung and Erickson, 1994). 
The expression o f  the membrane bound proteoglycan syndecan is 
altered during w ound healing in the epidermis and the granulation 
tissue, the sites where we found changes in tenascin-C expression as 
well (Elenius et al, 1991; Oksala et al, 1995). Expression o f  the 
glycoprotein annexin II during wound healing has not been 
studied, but annexin II is present on the surface o f  keratinocytes in 
vitro and in vivo in normal and pathologic conditions (Culard et al, 
1992; Bastian et al, 1993; M a et al, 1994). Moreover, recent findings 
o f  C hung et al (1996) support the idea that annexin II could have a 
major role in tenascin-C-mediated effects on cell migration.
W e conclude that keratinocytes are a major source o f  tenascin-C 
in the early phase o f  normal human wound healing, and we 
hypothesize that tenascin-C may have an anti-adhesive effect on 
keratinocytes.
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